In vitro assays, in vivo imaging, and biodistribution studies showed that [18F]FP-d-Lys6-GnRH exhibited high affinity for the GnRH receptor, predominant gall bladder system elimination, and specific tumor uptake in tumor xenografts. Here, GNRHR is linked to neoplasm.